These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 3928685

  • 1. Treatment with aldose reductase inhibitor or with myo-inositol arrests deterioration of the electroretinogram of diabetic rats.
    MacGregor LC, Matschinsky FM.
    J Clin Invest; 1985 Aug; 76(2):887-9. PubMed ID: 3928685
    [Abstract] [Full Text] [Related]

  • 2. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
    Gillon KR, Hawthorne JN, Tomlinson DR.
    Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
    [Abstract] [Full Text] [Related]

  • 3. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
    Schmidt RE, Plurad SB, Sherman WR, Williamson JR, Tilton RG.
    Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
    [Abstract] [Full Text] [Related]

  • 4. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
    Beyer-Mears A, Ku L, Cohen MP.
    Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
    [Abstract] [Full Text] [Related]

  • 5. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
    Whiting PH, Ross IS.
    Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
    [Abstract] [Full Text] [Related]

  • 6. Sorbitol, myo-inositol, and rod outer segment phagocytosis in cultured hRPE cells exposed to glucose. In vitro model of myo-inositol depletion hypothesis of diabetic complications.
    Del Monte MA, Rabbani R, Diaz TC, Lattimer SA, Nakamura J, Brennan MC, Greene DA.
    Diabetes; 1991 Oct; 40(10):1335-45. PubMed ID: 1936595
    [Abstract] [Full Text] [Related]

  • 7. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A, Cruz E.
    Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition.
    Goldfarb S, Simmons DA, Kern EF.
    Trans Assoc Am Physicians; 1986 Jan; 99():67-72. PubMed ID: 3111062
    [No Abstract] [Full Text] [Related]

  • 13. Experimental diabetes mellitus impairs the function of the retinal pigmented epithelium.
    MacGregor LC, Matschinsky FM.
    Metabolism; 1986 Apr; 35(4 Suppl 1):28-34. PubMed ID: 3007925
    [Abstract] [Full Text] [Related]

  • 14. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH, Tomlinson DR.
    Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition.
    Greene DA, Mackway AM.
    Diabetes; 1986 Oct; 35(10):1106-8. PubMed ID: 3019804
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR, Moriarty RJ, Mayer JH.
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.